跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
神經學科
醫學院
醫學系
電話
+886-2-22490088#8112
電子郵件
[email protected]
網站
http://medschool.tmu.edu.tw/main.php
郵寄地址
在地圖上顯示
No. 250 Wu-Xing Street
11031
Taipei
概覽
指紋
網路
專家檔案
(15)
專案
(92)
研究成果
(700)
資料集
(13)
指紋
查看啟用 神經學科 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Neuroscience
Brain Ischemia
95%
Parkinson's Disease
71%
Alzheimer's Disease
40%
Meta-Analysis
36%
Cognitive Disorders
28%
Cerebral Hemorrhage
26%
Obstructive Sleep Apnea
25%
Randomized Controlled Trial
24%
Amyloid
13%
Artificial Neural Network
12%
Cognitive Function
12%
Neurotrauma
12%
Traumatic Brain Injury
12%
Diabetes Mellitus
12%
Mild Cognitive Impairment
11%
Middle Cerebral Artery
10%
Aspirin
9%
In Vivo
9%
Migraine
8%
Magnetic Resonance Imaging
8%
In Vitro
8%
Sleep Disorder
8%
Neurodegenerative Disorder
8%
Platelet
7%
Sleep Quality
7%
Clopidogrel
7%
Multiple Sclerosis
7%
Neuroprotective Agent
7%
Polysomnography
7%
Cerebral Autoregulation
6%
Functional Magnetic Resonance Imaging
6%
Brain Tumor
6%
Nerve Excitability
6%
Rapid Eye Movement Sleep
6%
Antioxidant
6%
Stem Cell
6%
Ischemic Heart Disease
6%
Alteplase
5%
Acetylcholinesterase Inhibitor
5%
Cell Death
5%
Glioblastoma Multiforme
5%
Temozolomide
5%
Excitability
5%
Cell Signaling
5%
Blood Brain Barrier
5%
Peripheral Neuropathy
5%
Stenosis
5%
Tissue Plasminogen Activator
5%
Promoter Region
5%
Magnetic Resonance Imaging
5%
Brain-Derived Neurotrophic Factor
5%
Ischemia
5%
Cyanocobalamin
5%
Tau Protein
5%
Medicine and Dentistry
Apoplexy
100%
Brain Ischemia
48%
Cohort Analysis
35%
Parkinson's Disease
34%
Meta-Analysis
26%
Alzheimer's Disease
24%
Cerebral Hemorrhage
20%
Hazard Ratio
18%
Randomized Controlled Trial
18%
Odds Ratio
18%
Blood Clot Lysis
15%
Diabetes
13%
Systematic Review
13%
Disease
13%
Biological Marker
12%
Retrospective Cohort Study
12%
Obstructive Sleep Apnea
12%
Symptom
11%
Magnetic Resonance Imaging
10%
Alteplase
9%
Prevalence
8%
Brain Infarction
7%
Blood Pressure
7%
Cognitive Defect
7%
Drug Therapy
6%
National Institutes of Health Stroke Scale
6%
Proportional Hazards Model
6%
Clinical Trial
6%
Disseminated Herpes Zoster
6%
Maturity Onset Diabetes of the Young
6%
Combination Therapy
6%
Amyloid
6%
Acetylcholinesterase Inhibitor
6%
Traumatic Brain Injury
6%
Hyperglycemia
5%
Logistic Regression Analysis
5%
Adverse Event
5%
Auriculotherapy
5%
Headache
5%
Heart Arrest
5%
Cardiovascular Disease
5%
Excitability
5%
Infarction
5%
Glioblastoma
5%
Disability
5%
Diabetic Neuropathy
5%
Atrial Fibrillation
5%
Migraine
5%
Cognition
5%
Programmed Cell Death
5%
Targeted Temperature Management
5%
Malignant Neoplasm
5%
Pharmacology, Toxicology and Pharmaceutical Science
Brain Ischemia
51%
Parkinson's Disease
48%
Cohort Study
33%
Alzheimer's Disease
21%
Randomized Controlled Trial
19%
Sleep Disordered Breathing
17%
Brain Hemorrhage
14%
Disease
11%
Symptom
11%
Mouse
9%
Acetylsalicylic Acid
9%
Glioblastoma
9%
Cognitive Defect
8%
Clinical Trial
8%
Malignant Neoplasm
8%
Amyloid
8%
Sleep Disorder
8%
Diabetes Mellitus
8%
Cardiovascular Disease
7%
Adverse Event
7%
Clopidogrel
7%
Neuroprotective Agent
7%
Traumatic Brain Injury
7%
Biological Marker
7%
Alteplase
6%
Tumor Necrosis Factor
6%
Cholinesterase Inhibitor
6%
Combination Therapy
6%
Dopamine Receptor Stimulating Agent
6%
Thrombus
6%
Prevalence
6%
Rankin Scale
5%
Non Insulin Dependent Diabetes Mellitus
5%
Motor Dysfunction
5%
Atrial Fibrillation
5%
Cerebrovascular Accident
5%